Published in Br J Gen Pract on January 01, 2014
Low vitamin D prevalence at the GP practice. Br J Gen Pract (2015) 0.75
A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85
Summary of the Updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc (2011) 4.98
From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr (2008) 3.04
Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev (2013) 2.87
Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev (2011) 2.72
Over-the-counter and compounded vitamin D: is potency what we expect? JAMA Intern Med (2013) 2.53
Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med (2012) 2.15
Vitamin D deficiency induces early signs of aging in human bone, increasing the risk of fracture. Sci Transl Med (2013) 1.65
Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet (2010) 8.27
The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care (2012) 2.33
Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care (2012) 2.32
Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. J Clin Endocrinol Metab (2013) 1.83
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Curr Med Res Opin (2006) 1.44
Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin. BMJ Open (2011) 1.29
The medico-legal aspects of prescribing vitamin D. Br J Clin Pharmacol (2014) 1.14
The impact of the overactive bladder on health-related utility and quality of life. BJU Int (2006) 1.05
What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. J Clin Endocrinol Metab (2012) 1.02
External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations. Diabetes Care (2013) 0.89
The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010). Child Adolesc Psychiatry Ment Health (2013) 0.88
An overview and commentary on retrospective, continuous glucose monitoring for the optimisation of care for people with diabetes. Curr Med Res Opin (2009) 0.84
The impact of treatment non-compliance on mortality in people with type 1 diabetes. J Diabetes Complications (2012) 0.84
Deriving health state utilities for the numerical pain rating scale. Health Qual Life Outcomes (2011) 0.80
Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health Qual Life Outcomes (2014) 0.79
Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study. BMJ Open (2013) 0.78
Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study. Clin Ther (2011) 0.77
Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data. Rheumatology (Oxford) (2013) 0.77
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial. J Crohns Colitis (2008) 0.76
Ischaemic heart disease in men. Heart (2007) 0.75